RxDoctor Payments Data

Brandy Standifer, APRN

Family · Pikeville, KYNPI 1932845153

Payments from drug & device makers

$2,612in general payments, 2019–2025

Across 190 payments — averaging $13.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$819
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$406
  • Boehringer Ingelheim$267
  • Merck$183
  • Pfizer$166
  • Actelion Pharmaceuticals US, Inc.$123
  • plus $648 from 17 others

What the payments were for

  • Food & beverage$2,51396%
  • Education$994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,612 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$22,964
Medicare patients
330
Services billed
440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban243$201,991
EntrestoSacubitril/Valsartan168$142,493
XareltoRivaroxaban68$51,161
FarxigaDapagliflozin Propanediol50$42,601
Repatha SureclickEvolocumab44$31,558
JardianceEmpagliflozin28$26,589
Praluent PenAlirocumab12$7,458
VascepaIcosapent Ethyl16$6,778
Potassium Chloride269$4,020
Clonidine15$4,004
Ranolazine ErRanolazine67$3,482
Metoprolol Succinate405$3,315
Atorvastatin Calcium353$2,326
Bumetanide60$2,134
Losartan Potassium180$1,407

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$166$201,991243 claims
NovartisEntresto$819$142,493168 claims
AstraZenecaFarxiga$74$42,60150 claims
Boehringer IngelheimJardiance$267$26,58928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Pikeville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →